These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1631 related items for PubMed ID: 19279051

  • 41. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 42. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
    Adam HJ, Schurek KN, Nichol KA, Hoban CJ, Baudry TJ, Laing NM, Hoban DJ, Zhanel GG.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
    [Abstract] [Full Text] [Related]

  • 43. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E.
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [Abstract] [Full Text] [Related]

  • 44. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV.
    Clin Infect Dis; 2005 Jan 15; 40(2):225-35. PubMed ID: 15655739
    [Abstract] [Full Text] [Related]

  • 45. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P, Torres MJ, Aznar J.
    Enferm Infecc Microbiol Clin; 2012 Apr 15; 30(4):180-3. PubMed ID: 22365183
    [Abstract] [Full Text] [Related]

  • 46. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 15; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 47. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
    Daporta MT, Muñoz Bellido JL, Guirao GY, Hernández MS, García-Rodríguez JA.
    Int J Antimicrob Agents; 2004 Aug 15; 24(2):185-7. PubMed ID: 15288320
    [Abstract] [Full Text] [Related]

  • 48. Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England.
    Orr D, Wilkinson P, Moyce L, Martin S, George R, Pichon B.
    J Antimicrob Chemother; 2010 Mar 15; 65(3):449-52. PubMed ID: 20019170
    [Abstract] [Full Text] [Related]

  • 49. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 50. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.
    Yan SS, Schreckenberger PC, Zheng X, Nelson NA, Harrington SM, Tjhio J, Fedorko DP.
    Diagn Microbiol Infect Dis; 2008 Oct 15; 62(2):205-9. PubMed ID: 18554840
    [Abstract] [Full Text] [Related]

  • 51. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
    LaPlante KL, Rybak MJ, Tsuji B, Lodise TP, Kaatz GW.
    Antimicrob Agents Chemother; 2007 Apr 15; 51(4):1315-20. PubMed ID: 17296740
    [Abstract] [Full Text] [Related]

  • 52. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
    Albertí S, Cortés G, García-Rey C, Rubio C, Baquero F, García-Rodríguez JA, Bouza E, Aguilar L.
    Antimicrob Agents Chemother; 2005 Jan 15; 49(1):418-20. PubMed ID: 15616324
    [Abstract] [Full Text] [Related]

  • 53. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.
    Baucheron S, Chaslus-Dancla E, Cloeckaert A.
    J Antimicrob Chemother; 2004 Apr 15; 53(4):657-9. PubMed ID: 14985270
    [Abstract] [Full Text] [Related]

  • 54. Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.
    Petrelli D, Di Luca MC, Prenna M, Bernaschi P, Repetto A, Vitali LA.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 15; 33(2):241-4. PubMed ID: 24002218
    [Abstract] [Full Text] [Related]

  • 55. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.
    Clin Infect Dis; 2003 Feb 01; 36(3):380-3. PubMed ID: 12539083
    [Abstract] [Full Text] [Related]

  • 56. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM.
    J Antimicrob Chemother; 2009 May 01; 63(5):917-20. PubMed ID: 19297378
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).
    Davies TA, Goldschmidt R, Pfleger S, Loeloff M, Bush K, Sahm DF, Evangelista A.
    J Antimicrob Chemother; 2003 Aug 01; 52(2):168-75. PubMed ID: 12837740
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 82.